215530-24-8

Basic information

• Product Name: ethyl [6-[3-[4-(diphenylmethoxy)-piperidino]propylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]carboxylate
• Synonyms: ethyl [6-[3-[4-(diphenylmethoxy)-piperidino]propylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]carboxylate
• CAS NO: 215530-24-8
• Molecular Weight: 527.666
• Mol File: 215530-24-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: ethyl [6-[3-[4-(diphenylmethoxy)-piperidino]propylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl [6-[3-[4-(diphenylmethoxy)-piperidino]propylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]carboxylate(215530-24-8)
• EPA Substance Registry System: ethyl [6-[3-[4-(diphenylmethoxy)-piperidino]propylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]carboxylate(215530-24-8)

Safety Data

• Hazardous Substances Data: 215530-24-8(Hazardous Substances Data)

Upstream product

• 929-61-3 ethyl octyl ether 
• 14714-18-2 ethyl 6-Chloro-2-methylimidazo[1,2-b]pyridazine-3-carboxylate 
• 144-55-8 sodium hydrogencarbonate 
• 101620-72-8 1-(3-aminopropyl)-4-diphenylmethoxypiperidine 
• 609-15-4 ethyl 2-chloro-3-oxo-butyrate 

Downstream Products

• 215530-25-9 [6-[3-[4-(diphenylmethoxy)piperidino]-propylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]carboxylic acid 

Relevant articles and documents

NASAL DROPS CONTAINING FUSED PYRIDAZINE DERIVATIVES

A nose drop containing the compound (I) represented by the formula wherein Ar1 and Ar2 are each an aromatic group, Ar1 and Ar2 optionally form a condensed cyclic group together with the adjacent carbon atom, ring B is a nitrogen-containing heterocycle, X and Y are each a bond, an oxygen atom or S(O)p (p is 0 to 2), NR4 (R4 is H or a lower alkyl group) or a divalent linear lower hydrocarbon group optionally having substituents and containing 1 to 3 heteroatoms, A is N or CR7 (R7 is H, a halogen atom, a hydrocarbon group, an acyl group or a hydroxy group optionally having substituents), R1, R2 and R3 are each H, a halogen atom, a hydrocarbon group, an acyl group or a hydroxy group optionally having substituents, and R8 is H, a hydroxy group optionally substituted by a lower alkyl group or a carboxyl group, provided that the nitrogen-containing heterocycle represented by ring B is not a heterocycle represented by the formula wherein n is 0 - 1, or a salt thereof or a prodrug thereof, exhibits a superior prophylactic or therapeutic effect on allergic rhinitis and the like.